SEC Filing Details

Document Details

Form
Filing Date
02-16-2021
Document Date
12-31-2020
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Taysha Gene Therapies
Issuer
TAYSHA GENE THERAPIES, INC.
Scroll to top